Policy & Legislation
News on government policy and legislation impacting life science and diagnostics.
Trump Signs Executive Order on Matching US Drug Costs to Lower Prices Abroad
In his first term, pharmaceutical companies took the "most favored nation" policy to court over the White House's effort to slash costs for patients.
New Preclinical Testing Tools Help Researchers Tailor Treatment but Can They Fully Replace Mice?
Premium
Makers of organoids and cell models cheered the decision and said it will bolster the development of precision medicines, while others remain skeptical.
Newly Formed Advocacy Group Urges FDA Action on Alzheimer's Disease Risk Gene
The ApoE4 Alzheimer's Alliance is calling for an increased focus on patients with ApoE4, a gene variant associated with increased Alzheimer's risk.
Health Insurance Coverage for Biomarker Testing Becomes Law in New Jersey
State-regulated insurers in New Jersey must now cover biomarker testing for diagnosis, treatment, and monitoring.
The Sunshine Genetics Act would establish a consortium that plans to sequence 10,000 newborns for up to 600 rare conditions.